SCHEMBL15230780

SCHEMBL15230780

CC1(C)OB(c2cccc3nccnc23)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
LPL P06858 7/20 0.35
LIPG Q9Y5X9 7/20 0.35
HSD11B1 P28845 3/20 0.33
EGFR P00533 2/20 0.33
HSD17B10 Q99714 1/20 0.32
CISD1 Q9NZ45 1/20 0.32
PKM P14618 1/20 0.31
TSHR P16473 1/20 0.31
JAK2 O60674 1/20 0.30
BTK Q06187 1/20 0.30
ALPL P05186 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30682111 0.89 LPL (0.34) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL15158988 0.82 LPL (0.37) LPLLIPG
SCHEMBL30774154 0.80 KDM4E (0.44) MAPTALDH1A1KDM4EMEN1POLB
SCHEMBL30728958 0.80 KDM4E (0.44) MAPTALDH1A1KDM4EMEN1POLB
SCHEMBL1068456 0.80 KDM4E (0.44) MAPTALDH1A1KDM4EMEN1POLB
SCHEMBL481508 0.79 MAPT (0.42) MAPTALDH1A1KDM4EMEN1POLB
SCHEMBL26921895 0.79 ADRA2A (0.37) MEN1KMT2ALPLLIPGJAK2
SCHEMBL29982045 0.79 MAPT (0.42) MAPTALDH1A1KDM4EMEN1POLB
SCHEMBL3308271 0.78 ADRA2A (0.34) LPLLIPGEGFR
SCHEMBL14785705 0.77 KMT2A (0.41) MAPTALDH1A1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221695-A Compound, photoelectric device, light absorption sensor, sensor-embedded display panel, and electronic apparatus 三星电子株式会社 2024-06-21 CN disclosed
US-9394297-B2 Amides as pim inhibitors AMGEN INC. (US) 2016-07-19 US disclosed
US-20150329538-A1 AMIDES AS PIM INHIBITORS AMGEN INC. (US) 2015-11-19 US disclosed
WO-2014022752-A1 MACROCYCLES AS PIM INHIBITORS AMGEN INC. (US) 2014-02-06 WO disclosed
WO-2013130660-A1 AMIDES AS PIM INHIBITORS AMGEN INC. (US) 2013-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329538-A1 AMIDES AS PIM INHIBITORS PIM1, PIM3, PIM2 MAPT 3261/4885ALDH1A1 720/4885KDM4E 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.